Global Consensus on the Management of Spinal Infections: Recommendations From International Consensus Meeting 2025 Authors: Shanmuganathan Rajasekaran, Javad Parvizi Published: 2026 Shanmuganathan Rajasekaran, MS (Ortho), DNB, FRCS, MCh, PhD Javad Parvizi, MD, FRCS Spinal infections pose considerable challenges in management. First, they form a heterogeneous group due to the variable microbiology, diverse pathology, and differing natural history. Second, they have inherent potential for neurological and systemic consequences with delays in diagnosis or mistreatment. Third, there is a wide variability in the management protocols globally. Differences in socio-economic conditions, health care infrastructure, endemic disease patterns, and access to diagnostics and safe surgery influence clinical practice worldwide. Further, high-quality evidence and randomized trials are often not available, and the surgeon is often compelled to go by his experience or expert opinions to guide his management decisions. Against this background, the International Consensus Meeting (ICM) on Spinal Infections, held in May 2025 in Istanbul, Turkey, represents an important milestone. It was held as a part of the well-established and reputed ICM on prosthetic joint infections and was very successful in its aim to produce a robust, transparent, and reproducible methodology to develop global guidelines and recommendations. The strengths of the ICM on spinal infections were many. It involved 132 surgeons from 32 countries worldwide and truly represented a global opinion on this complex subject. It adopted a very rigorous and scientific process of 11 steps, where more than 300 clinically relevant questions were initially generated by the participating surgeons, reflecting the spectrum of uncertainty in this field. The questions were then systematically ranked by the international experts and distilled to 73 high-impact questions, ensuring that the ICM focused on issues of greatest relevance to daily practice. Another highlight was the decision to address tubercular and pyogenic spondylodiscitis through parallel but different consensus pathways. Although often grouped under the umbrella of “spinal infection,” these entities differ fundamentally in disease biology, diagnostic complexity, treatment duration, and surgical indications. This distinction is particularly crucial in geographic areas where both conditions co-exist but clinically require completely different management strategies. Centralised literature review, systematic grading of evidence, transparent documentation of voting outcomes, and healthy discussion of surgeons worldwide on each controversy made the process more rigorous and scientifically robust. Each recommendation was finally subjected to formal voting by more than 55 delegates from around the world during the face-to-face consensus meeting in Istanbul. Such depth of collective validation with transparent discussion enhances the value and global acceptability of the recommendations. Beyond its immediate contribution to spinal infection care, the value of this process lies in providing a reproducible template for future development of international guidelines. There are many areas of orthopaedic and spine practice that face similar challenges: high clinical variability, limited or absence of high-quality evidence, and considerable variability in global practice. The ICM has provided a model that can be easily replicated to address such deficiencies. In fact, the process and methodology are one of the meeting’s most valuable contributions. Understandably, the entire process relied heavily on the previous experience of the International Consensus Meeting group, the hard work and able assistance of the Secretariat, and the wisdom and enthusiastic participation of the global experts. We take this opportunity to acknowledge their contribution.